UnitedHealth Group reported strong third-quarter results with a 12% year-over-year revenue growth and a 23% increase in adjusted earnings per share. Management expressed confidence in continued growth, strategic expansions, and robust performance outlook for the remainder of the year and into 2017. These positive indicators are likely to bolster investor sentiment in the short term.

[1]